Deceleration capacity of heart rate predicts 1-year mortality in patients undergoing transcatheter edge-to-edge mitral valve repair
- PMID: 36946388
- PMCID: PMC10189076
- DOI: 10.1002/clc.24007
Deceleration capacity of heart rate predicts 1-year mortality in patients undergoing transcatheter edge-to-edge mitral valve repair
Abstract
Background: Risk stratification for transcatheter procedures in patients with severe mitral regurgitation is challenging. Deceleration capacity (DC) has already proven to be a reliable risk predictor in patients undergoing transcatheter aortic valve implantation. We hypothesized, that DC provides prognostic value in patients undergoing transcatheter edge-to-edge mitral valve repair (TEER).
Methods: We retrospectively analyzed electrocardiogram signals from 106 patients undergoing TEER at the University Hospital of Tübingen. All patients received continuous heart-rate monitoring to assess DC following the procedure. One-year all-cause mortality was defined as the primary end point.
Results: Sixteen patients (15.1%) died within 1 year. The DC in nonsurvivors was significantly reduced compared to survivors (5.1 ± 3.0 vs. 3.0 ± 1.6 ms, p = 0.002). A higher EuroSCORE II and impaired left ventricular function were furthermore associated with poor outcome. In Cox regression analyses, a DC < 4.5 ms was found a strong predictor of 1-year mortality (hazard ratio: 0.10, 95% confidence interval: 0.13-0.79, p = 0.029). Finally, a significant negative correlation was found between DC and residual mitral regurgitation after TEER (r = -0.41, p < 0.001).
Conclusion: In patients with severe mitral regurgitation undergoing TEER, DC may serve as a new predictor of follow-up mortality.
Keywords: MitraClip; cardiac autonomic dysfunction; deceleration capacity; mortality.
© 2023 The Authors. Clinical Cardiology published by Wiley Periodicals LLC.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez‐Sarano M. Burden of valvular heart diseases: a population‐based study. Lancet. 2006;368(9540):1005‐1011. - PubMed
-
- Beyersdorf F, Vahanian A, Milojevic M, et al. 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur J Cardiothorac Surg. 2021;60:727‐800. - PubMed
-
- Feldman T, Kar S, Elmariah S, et al. Randomized comparison of percutaneous repair and surgery for mitral regurgitation. JACC. 2015;66(25):2844‐2854. - PubMed
-
- Lim DS, Reynolds MR, Feldman T, et al. Improved functional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation after transcatheter mitral valve repair. JACC. 2014;64(2):182‐192. - PubMed
-
- Stone GW, Lindenfeld J, Abraham WT, et al. Transcatheter mitral‐valve repair in patients with heart failure. N Engl J Med. 2018;379(24):2307‐2318. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources